The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Enzyme Inhibitors

This is a "connection" page, showing publications Olatoyosi Odenike has written about Enzyme Inhibitors.
Connection Strength

0.703
  1. Incorporating novel approaches in the management of MDS beyond conventional hypomethylating agents. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):460-469.
    View in: PubMed
    Score: 0.484
  2. Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis. J Clin Oncol. 2021 09 10; 39(26):2881-2892.
    View in: PubMed
    Score: 0.154
  3. Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clin Cancer Res. 2008 Nov 01; 14(21):7095-101.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.